TABLE 2. The distribution of variants in LDLR, PCSK9 and APOB in the 283 subjects with a total cholesterol level ≥290 mg/dL from the Dong-gu Study and the Namwon Study.
*Subject with a total cholesterol level ≥310 mg/dL.
*Subject with a total cholesterol level ≥310 mg/dL.